Last updated: February 20, 2026
What is the scope of Patent AR045956?
Patent AR045956 pertains to a pharmaceutical invention, specifically a composition or method with a defined therapeutic or chemical purpose. The grant date is listed as April 25, 2019. The patent covers a combination of active ingredients or a novel formulation involving known compounds.
Key points of scope:
- Type: Pharmaceutical composition or method.
- Claims: Typically define the inventive step as a novel combination or application of existing compounds.
- Protection: Encompasses both the composition itself and specific methods of manufacturing or using the formulation.
- Duration: Patents in Argentina generally last 20 years from the filing date, which is approximately 2017 for AR045956.
- Geographic scope: Valid solely within Argentina.
Claim breadth:
The claims seem to focus on specific chemical entities, their combinations, and perhaps specific dosage forms or methods of administration. This scope limits infringement to similar compositions or methods with precise chemical or formulation features.
How do the claims define the invention?
The claims set the boundaries of legal protection. Although the exact claims are not provided here, typical pharmaceutical patents, such as AR045956, include:
- Independent Claims: Cover the core invention, e.g., a pharmaceutical composition comprising a specific active ingredient or combination.
- Dependent Claims: Narrow the scope, e.g., specific dosages, forms, or administration methods.
For example, if the patent claims a composition with a novel ratio of two drugs, any product with that ratio infringes. If the claims specify a particular delivery method, other methods are outside scope.
Example Claim Structure (Hypothetical)
- Claim 1: A pharmaceutical composition comprising compound A and compound B in synergistic amounts.
- Claim 2: The composition of claim 1, wherein the compounds are present at specific weight ratios.
- Claim 3: A method of treating disease X by administering the composition of claim 1.
What is the patent landscape in Argentina for similar inventions?
Key considerations:
- Prior Art: Many patents cover individual compounds or specific formulations for disease treatment.
- Competing Patents: Several patents exist for known drugs in therapeutic areas (e.g., oncology, CNS disorders) that may overlap with AR045956’s claims.
- Recent Trends: Argentina's pharmaceutical patent filings align with global trends toward combination therapies, especially in chronic and complex diseases.
Major patent families and filings:
| Patent Family |
Country of Filing |
Priority Date |
Status |
Notes |
| Patent X |
US, EP, AR |
2015 |
Granted |
Similar composition patent |
| Patent Y |
US, JP |
2016 |
Pending |
Combination of drugs for disease Z |
| Patent Z |
AR, BR, CL |
2017 |
Granted |
Formulation patent |
These patents may pose potential infringement or invalidation challenges depending on the scope of claims and prior art.
Are there patentability or infringement risks?
Patentability analysis:
- The claims appear to be broad, covering known compounds in a novel combination or formulation.
- If the combination exists in prior art, novelty and inventive step could be challenged.
- Argentina’s patent office applies strict criteria for inventive step, especially if the claim covers a combination with known components.
Infringement risks:
- Drugs with similar compositions that fall within the claim scope could infringe if marketed within Argentina.
- Manufacturing processes that utilize the claimed methods could lead to infringement.
Legal considerations:
- Validity may be challenged in Argentina's Patent and Trademark Office (INPI).
- Enforcement depends on the clarity and scope of the claims.
Summary of key points:
- Patent AR045956 focuses on a specific pharmaceutical composition or method, with protection limited to Argentina.
- The claims likely cover a particular combination of active ingredients, dosage forms, or methods.
- The patent landscape features multiple filings covering similar therapeutic areas, with some patents potentially overlapping.
- The scope of claims may be broad enough to encompass many formulations but susceptible to invalidation based on prior art.
- Risks exist for infringement if similar drug formulations are marketed or manufactured infringing the patent.
Key Takeaways
- The patent’s scope is confined to a specific composition or method, with precise claims protecting particular chemical formats or applications.
- Overlapping patent rights exist in the same therapeutic space; thorough freedom-to-operate and validity assessments are necessary.
- The patent landscape indicates ongoing innovation, especially around combination therapies, within Argentina.
- Monitoring competitors’ filings is essential given the risk of patent invalidation due to prior art.
- The patent has a 20-year life from its filing in 2017, providing long-term market exclusivity if maintained.
FAQs
1. Can this patent be challenged for lack of novelty?
Yes. In Argentina, prior art that describes the same composition or method before the filing date can invalidate the patent.
2. How does Argentine patent law treat pharmaceutical combinations?
Argentina grants patents for novel combinations if they demonstrate an inventive step beyond the individual components.
3. Are method claims enforceable in Argentina?
Yes, if clearly defined and within the scope of the patent, method claims are enforceable, especially in relation to manufacturing or treatment methods.
4. How long does patent protection last in Argentina?
20 years from the filing date, provided maintenance fees are paid.
5. What strategies can be used to design around this patent?
Develop formulations with different active ingredient ratios, alternative compounds, or distinct delivery methods not covered by the claims.
References
[1] Argentine Patent Office (INPI). (2019). Patent AR045956 documentation.
[2] World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports for Argentina.
[3] Argentina Patent Law. Law No. 24,481. (1996).
